Affordable Access

Two-year clinical outcome after successful implantation of drug-eluting and bare metal stents in diabetic patients: results from a real-world single center registry.

Authors
  • Dou, Ke-Fei
  • Xu, Bo
  • Yang, Yue-Jin
  • Chen, Ji-Lin
  • Qiao, Shu-Bin
  • Li, Jian-Jun
  • Qin, Xue-Wen
  • Liu, Hai-Bo
  • Wu, Yong-Jian
  • Chen, Jue
  • Yao, Min
  • You, Shi-Jie
  • Yuan, Jin-Qing
  • Dai, Jun
  • Gao, Run-Lin
Type
Published Article
Journal
Chinese medical journal
Publication Date
Mar 20, 2009
Volume
122
Issue
6
Pages
612–616
Identifiers
PMID: 19323921
Source
Medline
License
Unknown

Abstract

In contemporary society's large, diabetic population, the use of DES is associated with long-term significant reductions in the risks of TLR, TVR, and any revascularization. There is no significant difference in all-cause mortality, MI, and thrombosis between DES and BMS in the patients with diabetes at 24-month follow-up.

Report this publication

Statistics

Seen <100 times